designer491/iStock via Getty Images
Royalty Pharma (NASDAQ:RPRX) is a profitable, dividend paying company with a business model which involves buying royalty streams. It has provided funding for unprofitable biotech companies, funded R&D projects for large pharma companies and purchased royalties from commercial products such as
Analyst’s Disclosure:I/we have a beneficial long position in the shares of VRTX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This is not a recommendation to buy or sell any security and I am not a financial advisor. Investors should perform their own due diligence and consult their financial advisor.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
